维普中文期刊产品整合服务
28篇 您的检索式:作者名="HADDI E"
    题名 作者 年代 出处 被引量
1Hepatocellular carcinoma: Review of disease and tumor biomarkers显示文摘Hepatocellular carcinoma(HCC) is a common malignancy and now the second commonest global cause of cancer death. HCC tumorigenesis is relatively silent and patients experience late symptomatic presentation. As the option for curative treatments is limited to early stage cancers, diagnosis in non-symptomatic individuals is crucial. International guidelines advise regular surveillance of high-risk populations but the current tools lack sufficient sensitivity for early stage tumors on the background of a cirrhotic nodular liver. A number of novel biomarkers have now been suggested in the literature, which may reinforce the current surveillance methods. In addition, recent metabonomic and proteomic discoveries have established specific metabolite expressions in HCC, according to Warburg's phenomenon of altered energy metabolism. With clinical validation, a simple and non-invasive test from the serum or urine may be performed to diagnose HCC, particularly benefiting low resource regions where the burden of HCC is highest.Jin Un Kim Mohamed I F Shariff Mary M E Crossey Maria Gomez-Romero Elaine Holmes I Jane Cox Haddy K S Fye Ramou Njie Simon D Taylor-Robinson 2016World Journal of Hepatology2016,8,10:13
2Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioio- dine therapy 显示文摘Durante C Haddy N Baudin E 2006J Clin Endocrinol Metab2006,91,8:1
3Long-term outcome of 444 patients with distant metastases fi'om papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy 显示文摘Durante C Haddy N Baudin E 2006] Clin Endocrinol Metab2006,9,8:1
4Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy 显示文摘Durante C Haddy N Baudin E 2006J Clin Endocfinol Metab2006,91,8:1
5Long-term outcomeof 444 patients with distant metastases from papillary andfollicular thyroid carcinoma:benefits and limits ofradioiodine therapy显示文摘Durante C Haddy N Baudin E 2006J Clin Endocrinol Metab2006,91,8:1
6Long-term outcome of 444 patients witⅡ distant metastases from papillary and follicular thyroid carcinoma:benefits and limits of radioiodine therapy显示文摘Durante C Haddy N Baudin E 0,,08:1
7Long-termoutcome of 444 patients with distant metastases from papillaryand follicular thyroid carcinoma: Benefits and limits ofradioiodine therapy 显示文摘DURANTE C HADDY N BAUDIN E 2006J Clin Endocrinol Metab2006,91,8:1
8The Role of Text Pre - processing in Sentiment Analysis 显示文摘Haddi E Liu X Shi Y 2013Procedia Computer Science2013,,17:1
9Comparision of the ACAREX test with monoclonal antibodies for the quantification of mite allergens显示文摘VAN DER BREMPT X HADDI E MICHEL-NGUYEN A 1991J Allergy Clin Immunol1991,87,:1
10Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma:benefits and limits of radioiodine therapy显示文摘Durante C Haddy N Baudin E 2006J Clin Endocrinol Metab2006,91,8:1
11Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioio- dine therapy显示文摘Durante C Haddy N Baudin E 2006J Clin Endocr Metab2006,91,8:1
12Long-term outcome of 444 patients with distant metastases from papillary and follicular thy- roid carcinoma: benefits and limits of radioiodine therapy显示文摘Durante C Haddy N Baudin E 2006J Clin Endocrinol Metab2006,91,8:1
13Long term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma:benefits and limits of radioiodine therapy显示文摘Durante C Haddy N Baudin E 0,,08:1
14Long-term outeome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy 显示文摘Durante C Haddy N Baudin E 2006J Clin Endocrinol Metab2006,91,8:1
15Long-termoutcome of 444 patients with distant metastases from papillaryand follicular thyroid carcinoma: benefits and limits ofradioiodine therapy显示文摘DURANTE C HADDY N BAUDIN E 2006J Clin Endocrinol Metab2006,91,8:1
16Long-term outcome of 444 patients with distant metastases from papillary and follicular thy- roid carcinoma: Benefits and limits of radioiodine therapy显示文摘Durante C Haddy N Baudin E 2006J Clin Endocrinol Metab2006,91,8:1
17Atopy and systemic reactions to drugs显示文摘Haddi E Charpin D Tafforeau M 1990Allergy1990,45,3:1
18Atopy and systemic reactions to drugs显示文摘HADDI E CHARPIN D TAFFOREAU M 1990Allergy1990,45,3:1
19Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma:benefits and limits of radioiodine therapy 显示文摘Durante C Haddy N Bandin E 2006J Clin Endocrinol Metab2006,91,:1
20Long-term outcome of 444 pa tients with distant metastases from papillary and follicular thyroid carcinoma:benefits and limits of radioiodine therapy显示文摘Durante C Haddy N Baudin E 0,,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费